Literature DB >> 12956200

The use of topical therapies to treat onychomycosis.

Aditya K Gupta1, Jennifer E Ryder, Robert Baran.   

Abstract

The management of onychomycosis using topical agents has improved with the introduction of ciclopirox and amorolfine nail lacquers; other topical agents may be less effective. The combination of a nail lacquer with an oral antifungal agent may further improve efficacy rates in certain clinical presentations (eg, among those individuals with severe onychomycosis). Topical agents have a favorable adverse events profile. Further studies are required on the treatment of onychomycosis with nail lacquers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956200     DOI: 10.1016/s0733-8635(03)00025-1

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  4 in total

Review 1.  Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.

Authors:  Alessandro Subissi; Daniela Monti; Giuseppe Togni; Federico Mailland
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

Review 2.  Amorolfine vs. ciclopirox - lacquers for the treatment of onychomycosis.

Authors:  Katarzyna Tabara; Anna E Szewczyk; Wojciech Bienias; Agnieszka Wojciechowska; Marta Pastuszka; Magdalena Oszukowska; Andrzej Kaszuba
Journal:  Postepy Dermatol Alergol       Date:  2015-02-03       Impact factor: 1.837

Review 3.  Onychomycosis: A Review.

Authors:  Bianca Maria Piraccini; Aurora Alessandrini
Journal:  J Fungi (Basel)       Date:  2015-03-27

Review 4.  Combination Therapy Should Be Reserved as Second-Line Treatment of Onychomycosis: A Systematic Review of Onychomycosis Clinical Trials.

Authors:  Julianne M Falotico; Rebecca Lapides; Shari R Lipner
Journal:  J Fungi (Basel)       Date:  2022-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.